All Stories

  1. State-level disparities in cervical cancer prevention and outcomes in the U.S.: a modeling study
  2. Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study
  3. Helicobacter pylori infection in the United States beyond NHANES: a scoping review of seroprevalence estimates by racial and ethnic groups
  4. Birth cohort and age-specific trends in global Helicobacter pylori seroprevalence: a scoping review
  5. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico
  6. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision
  7. State-level disparities in cervical cancer prevention and impact on outcomes in the U.S.: A modeling study
  8. Emulator-Based Bayesian Calibration of the CISNET Colorectal Cancer Models
  9. Characteristics of a cost-effective blood test for colorectal cancer screening
  10. A Fast Nonparametric Sampling (NPS) Method for Time-to-Event in Individual-Level Simulation Models.
  11. Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models
  12. Value of Information: Success Stories
  13. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics
  14. Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program
  15. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
  16. Breastfeeding is associated with the intelligence of school‐age children in Mexico
  17. Cost effectiveness of non‐drug interventions that reduce nursing home admissions for people living with dementia
  18. Emulator-based Bayesian calibration of the CISNET colorectal cancer models
  19. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics
  20. A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
  21. Dynamics of Respiratory Infectious Diseases in Incarcerated and Free-Living Populations: A Simulation Modeling Study
  22. An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
  23. Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison
  24. Characterization and Valuation of the Uncertainty of Calibrated Parameters in Microsimulation Decision Models
  25. CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis
  26. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study
  27. Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico
  28. Age-specific rates of onset of cannabis use in Mexico
  29. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies
  30. Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study
  31. COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors
  32. Dependence of COVID-19 Policies on End-of-Year Holiday Contacts in Mexico City Metropolitan Area: A Modeling Study
  33. Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients
  34. BayCANN: Streamlining Bayesian Calibration With Artificial Neural Network Metamodeling
  35. Covid-19 Vaccine Acceptance in California State Prisons
  36. Outbreaks of Covid-19 Variants in Prisons: A Mathematical Modeling Analysis of Vaccination and Re-Opening Policies
  37. Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors
  38. Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
  39. How do Covid-19 policy options depend on end-of-year holiday contacts in Mexico City Metropolitan Area? A Modeling Study
  40. Age-Specific Rates of Onset of Cannabis Use in Mexico
  41. The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review
  42. A Summary of the 2020 Gastric Cancer Summit at Stanford University
  43. Estimating population-based recurrence rates of colorectal cancer over time in the United States
  44. Cost-effectiveness analysis of a multidisciplinary health-care model for patients with type-2 diabetes implemented in the public sector in Mexico: A quasi-experimental, retrospective evaluation
  45. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
  46. Validation of Microsimulation Models Used for Population Health Policy
  47. Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers
  48. Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods
  49. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies
  50. A Multidimensional Array Representation of State-Transition Model Dynamics
  51. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis
  52. Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio
  53. Midwife‐led care and obstetrician‐led care for low‐risk pregnancies: A cost comparison
  54. A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer
  55. A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
  56. A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling
  57. A Multidimensional Array Representation of State-Transition Model Dynamics
  58. Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies
  59. “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier
  60. The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis
  61. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
  62. Nonidentifiability in model calibration and its implications for medical decision making.
  63. Revisiting assumptions about age-based sexual mixing representations in mathematical models
  64. Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis
  65. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model – CORRIGENDUM
  66. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model
  67. Microsimulation modeling in R: A tutorial
  68. A Kinked Health Insurance Market: Employer-Sponsored Insurance under the Cadillac Tax
  69. A Gaussian Approximation to efficiently compute the expected value of sample information (EVSI)
  70. Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis
  71. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?
  72. An Overview of R in Health Decision Sciences
  73. Modeling the Cost-Effectiveness of Doula Care Associated with Reductions in Preterm Birth and Cesarean Delivery
  74. Análisis de costo-beneficio: prevención del VIH/sida en migrantes en Centroamérica
  75. Registro de señales de EEG para aplicaciones de Interfaz Cerebro Computadora (ICC) basado en Potenciales Evocados Visuales de Estado Estacionario (PEVEE)